Williams Owen O

Show results for

Unknown (236)
Genomics (10)
Metabolomics (6)
Transcriptomics (4)

Organisms

Homo sapiens (10)
Mus musculus (3)
Saccharomyces cerevisiae (1)

Repository

EGA (10)
MetaboLights (6)
biostudies-arrayexpress (4)

Technology Type

Mass spectrometry (5)
Mass spectrometry assay (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (5)
GenePix 4000A [Axon Instruments] (2)
Liquid Chromatography MS - positive (1)

Publication Date

2023 (5)
2006 (2)
2014 (1)
2007 (1)
2024 (1)

CHEBI ID

CHEBI:35038 (3)
CHEBI:28865 (3)
CHEBI:16359 (3)
CHEBI:195271 (2)
CHEBI:143757 (2)
CHEBI:143745 (2)
CHEBI:182784 (2)
CHEBI:139138 (2)
CHEBI:73858 (2)
CHEBI:34494 (2)
CHEBI:27997 (2)
CHEBI:34687 (2)
CHEBI:64563 (2)
CHEBI:80774 (2)
CHEBI:173703 (2)
CHEBI:75342 (2)
CHEBI:27432 (2)
CHEBI:181874 (1)
CHEBI:75567 (1)
CHEBI:195266 (1)
CHEBI:195267 (1)
CHEBI:195270 (1)
CHEBI:195269 (1)
CHEBI:195265 (1)
CHEBI:181094 (1)
CHEBI:195272 (1)
CHEBI:191103 (1)
CHEBI:191092 (1)
CHEBI:181126 (1)
CHEBI:195264 (1)

Metabolite Name

Tris(2-butoxyethyl) phosphate (3)
Cholic acid (3)
(2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8aR,9R,12aS,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid (2)
Alpha-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid (2)
1-({[2-(2-furylmethyl)-5-methylpyrrolidinyl]amino}methylene)-7-[8-({[2-(2-fury lmethyl)pyrrolidinyl]amino}methylene)-1,6-dihydroxy-3-methyl-5-(methylethyl)-7 -oxo(2-naphthyl)]-3,8-dihydroxy-6-methyl-4-(methylethyl)naphthalen-2-one (2)
NCGC00385123-01_C22H30O6_7b,9-Dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate (2)
Lyso-PC(16:0) (2)
Dibutyl phthalate (DBP) (2)
2,6-Di-tert-butyl-4-hydroxymethylphenol (2)
Monoolein (2)
Elaidic acid (2)
Taurocholic acid (2)
1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (2)
9(10)-EpOME (2)
NCGC00168953-02_C47H76O17_(3beta,5xi,9xi,22beta)-22,24-Dihydroxyolean-12-en-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->2)-alpha-L-arabinopyranosyl-(1->2)-beta-D-glucopyranosiduronic acid (1)
Sodium taurochenodeoxycholate (1)
(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
(R)-4-((3R,4R,5S,8S,9S,10R,13R,14S,17R)-3,4-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
Lyso PC (22:6) (1)
Methyl (3R,4R,5R)-5-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(E)-3-phenylprop-2-enoyl]oxyoxan-2-yl]oxy-3,4-dihydroxycyclohexene-1-carboxylate (1)
Propanoic acid, 3,3'-thiobis-, didodecyl ester (1)
2-((R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid (1)
LU052302 Acetyl tributyl citrate|tributyl 2-acetyloxypropane-1,2,3-tricarboxylate (1)
9-Octadecenamide, (Z)- (1)
Ethanol, 2-(2-butoxyethoxy)- (1)
3beta-Hydroxy-5-cholenoic acid (1)
Hexanedioic acid, bis(2-ethylhexyl) ester (1)
9S-Hydroxy-10E,12Z,15Z-octadecatrienoic acid (1)
2-((4R)-4-((3R,5R,6S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid (1)
2-((R)-4-((3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid (1)

Study type

Transcription profiling by array (4)

Release Date

2021 (31)
2023 (24)
2022 (21)
2015 (19)
2024 (18)
2018 (18)
2025 (16)
2016 (14)
2019 (12)
2013 (11)
2020 (10)
2014 (9)
2017 (8)
2012 (7)
2011 (7)
2009 (5)
2026 (3)
2007 (2)
2006 (2)
2010 (1)
2008 (1)
2003 (1)

Previous page
1 / 26
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 26
Next page

Sort by:

Relevance

Page size

Developing Therapists' Multicultural Orientation Using Web-Based Deliberate Practice: An Initial Feasibility, Usability, and Acceptability Study.

Not available

S-EPMC11573355 | biostudies-literature

Is COMT a susceptibility gene for schizophrenia?

Not available

S-EPMC2526139 | biostudies-literature

A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain.

Not available

S-EPMC1180576 | biostudies-literature

Putative cortical dopamine levels affect cortical recruitment during planning.

Not available

S-EPMC3808120 | biostudies-literature

Deep Sequencing to Reveal Phylo-Geographic Relationships of Juquitiba Virus in Paraguay.

Not available

S-EPMC10537311 | biostudies-literature

An investigation of the antileishmanial properties of semi-synthetic saponins.

Not available

S-EPMC7651632 | biostudies-literature

Transcription profiling of mouse autofluorescent erythroid cells (defined as TER-119+) vs. Nkx2-5-GFP+ heterozygous cells at E9.5VCCRI_RPH)

Autofluorescent erythroid cells (defined as TER-119+) were compared to Nkx2-5-GFP+ heterozygous cells at E9.5.

ORGANISM(S): Mus musculus

2007-01-09 | E-MEXP-534 | biostudies-arrayexpress

Transcription profiling of mouse Nkx2-5 null cardiomyocytes

Nkx2-5-GFP+ cells were collected by FACS from whole embryos (E8.0-8.5, 5-12 ps) and dissected heart tubes (E9.0-9.5, 15-21 ps). Because limited numbers of cells were obtained from individual embryos (~300 cells at E8, ~1500 cells at E9.5) mRNA was amplified twice with T7 RNA polymerase and fluoresce...

ORGANISM(S): Mus musculus

2006-11-27 | E-MEXP-533 | biostudies-arrayexpress

A phase 1 study evaluating the safety, tolerability, and pharmacokinetics of the porcupine inhibitor, AZD5055.

Not available

S-EPMC12177174 | biostudies-literature

Pseudoexfoliation and Cataract Syndrome Associated with Genetic and Epidemiological Factors in a Mayan Cohort of Guatemala.

Not available

S-EPMC8303577 | biostudies-literature